Add 2 More Reports For 20% off

Report Overview

The global epistaxis device market is expected to grow at a CAGR of 5.4% during the forecast period of 2024-2032, driven by the rising incidence of epistaxis (nosebleeds) across the globe.

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Epistaxis Device Market Outlook

  • The market demand is anticipated to be driven by innovative product launches, playing a vital role in epistaxis management.
  • The strategic partnerships between key players to enhance the supply chain and treatment procedure for epistaxis are poised to boost market expansion in the forecast period.
  • Continuous technological developments in the market are collectively playing a crucial role in the market and also contributing to the market value.

Global Epistaxis Device Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Epistaxis Device Market Overview

Epistaxis is a medical term used for nosebleeds. Most nosebleeds are mild, self-limiting, and spontaneous, but some can be recurrent. Nosebleeds occur when a blood vessel bursts inside the nose. Epistaxis devices are most widely used for nose bleeding management and, thus, with the rise in functional endoscopic sinus surgery (FESS), the epistaxis device market is witnessing significant growth. As FESS is simple and minimally invasive, it has become the most preferred choice for patients with chronic rhinosinusitis (CRS). FESS is associated with problems that include the use of nasal paddings, such as nasal bleeding and adhesions. The market for epistaxis devices is driven by the rising partnerships and collaborations to bring new devices into the market, along with technical advancements, increased emphasis on early diagnosis and increasing prevalence of diseases like hypertension.

Epistaxis Device Market Growth Drivers

Growth in Product Launches to Boost Market Growth

It is estimated that nearly 60% of people will experience a nosebleed at least once in a lifetime. The occurrence of nosebleeds is also commonly recorded in children aged from 2 to 10 years and adults aged between 55 to 80 years old. In July 2023, NasaClip, Inc., a Baltimore-based medical device company that focuses on developing nose bleed management devices launched an innovative easy-to-use device called NasaClip. The device instantly provides constant, comfortable hands-free compression combined with intranasal sponges to stop the bleeding nose. It is the first FDA-approved device that comes with adjustable nasal compression for children. This cutting-edge development is poised to have a significant impact on the epistaxis market demand triggering competition and more innovations in the market. With curated features such as adjustable compression for children, this innovation is highly capable of being chosen as the first choice of healthcare providers to treat the condition, propelling the market demand.

Surge in Strategic Collaborations to Streamline Nosebleed Treatment

The epistaxis device market demand is driven by the increasing application of these devices in managing the condition. To meet the rising demand for these devices, several companies are collaborating to launch effective and technology-driven devices. For instance, in October 2023, SourceMark Medical, a United States-based medical device company and certified Minority Business Enterprise (MBE), signed a supplier partnership with NasaClip, an easy-to-use nosebleed rescue device available in adult and pediatric sizes to streamline the epistaxis treatment process. As the essence of this partnership is focused on maintaining appropriate supply it can help expand the reach of NasaClip to a wider audience, including hospitals, nursing homes, urgent care centers, schools, and sports facilities. With substantial expansion, the market is collectively poised to experience a higher market value in the forecast period.

Epistaxis Device Market Growth Trends

The market is witnessing several trends and developments to improve the current global scenario. Some of the notable trends are as follows:

Key Trends Impact
Technological Advancements The market is experiencing continuous technical advancements and innovation in epistaxis devices. This is leading to the development of more effective and user-friendly epistaxis devices, leading to market growth.
Rising Prevalence of Chronic Conditions Nasal bleeding is caused due to several underlying factors including chronic diseases such as hypertension. The rising prevalence of chronic conditions such as hypertension, nasal tumours, and nose bleeding disorders, responsible for recurrent nose bleeding is propelling the market growth.
Minimally Invasive Treatment Options The rising preference for minimally invasive treatments and procedures for tackling epistaxis is one of the notable market trends, contributing to market growth.
Increased Awareness and Diagnosis There is also a significant rise in awareness of epistaxis including causes and risks associated with nose bleeds. This has contributed to an increase in diagnosis incidence. Hence, the demand for effective treatment for epistaxis has increased.

Epistaxis Device Market Growth Segmentation

Market Breakup by Device Type

  • Nasal Packing Devices 
  • Nasal Tampons 
  • Nasal Sponges 
  • Nasal Plugs 
  • Cryotherapy Devices 
  • Others

Market Breakup by Material

  • Silicone 
  • Polyurethane 
  • Polyethylene 
  • Natural Materials 
  • Others

Market Breakup by Application

  • Anterior Epistaxis Treatment
  • Posterior Epistaxis Treatment 
  • Chronic Epistaxis Treatment 
  • Traumatic Epistaxis Treatment 
  • Others

Market Breakup by End User

  • Hospitals 
  • Ambulatory Surgical Centers 
  • Specialty clinics 
  • Homecare 
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific 
  • Latin America
  • Middle East and Africa

Global Epistaxis Device Market By Type

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Epistaxis Device Market Share

Epistaxis Device Based on Application Leads the Market Share

Based on application, the market segment is categorized into anterior epistaxis treatment, posterior epistaxis treatment, chronic epistaxis treatment, and traumatic epistaxis treatment, among others. The segment is led by anterior epistaxis treatment as anterior nose bleeds are most common, contributing to high prevalence and the majority of cases. The increasing availability of user-friendly, over-the-counter products for anterior nosebleed management is bolstering market demand, and driving growth in the segment.

Epistaxis Device Market Analysis by Region

Based on region, the market report covers North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Out of these, North America is significantly dominating the market. The dominance can be attributed to the high awareness among people about the available treatments and nosebleed disorders. The presence of a robust healthcare infrastructure and continuous technological development is a major factor justifying the dominance of the market share. The United States alone witnesses more than 500,000 ER visits for nosebleeds on an annual basis. Considering the incidence of ER visits, the requirement of the epistaxis devices is comparatively high hence, contributing to the escalating market demand, justifying the regional dominance.

Global Epistaxis Device Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Leading players in the Epistaxis Device Market

The key features of the market report comprise patent analysis, grants analysis, funding and investment analysis and strategic initiatives by the leading players. The major companies in the market are as follows:

Medtronic plc

Headquartered in Dublin, Ireland, Medtronic is one of the largest medical device companies in the world. Their product portfolio covers various medical domains including cardiac and vascular devices, minimally invasive therapies, restorative therapies, and diabetes.

Smith & Nephew plc

It is a British multinational medical equipment manufacturing company specialising in the development of advanced wound management products, arthroscopy products, trauma and clinical therapy products, and orthopaedic reconstruction products.

Johnson & Johnson (Ethicon)

Headquartered in New Jersey, USA, Johnson & Johnson (Ethicon) is a multinational pharmaceutical, biotechnology, and medical technologies conglomerate specialising in surgical instruments and technologies.

Stryker Corporation

It is an American multinational medical technologies corporation based in Kalamazoo, Michigan. The company has an impressive portfolio across different areas of healthcare including implants used in joint replacement and trauma surgeries, surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling and emergency medical equipment; neurosurgical, neurovascular, and spinal devices and other medical device products.

Cook Group

The Indiana-based company manufactures medical devices such as stents, catheters, vascular products, and devices involved in minimally invasive medicine. Tissue engineering and regenerative medicine products, drug delivery systems, and specialty pharmaceuticals are some of the prominent sectors of development.

Other key players in the market include Olympus Corporation, Boston Scientific Corporation, AbbVie Inc., and Karl Storz SE & Co. KG.

Key Questions Answered in the Epistaxis Device Market

  • What was the global epistaxis device market value in 2023? 
  • What is the global epistaxis device market forecast outlook for 2024-2032? 
  • What are the regional markets covered in the EMR report? 
  • What is market segmentation based on device type? 
  • What is the market breakup based on material? 
  • What are the major applications in the market? 
  • What are the major factors aiding the global epistaxis device market demand?
  • How has the market performed so far and how is it anticipated to perform in the coming years?
  • What are the market's major drivers, opportunities, and restraints?
  • Which regional market is expected to lead the market share in the forecast period?
  • Which country is expected to experience expedited growth during the forecast period?
  • What are the major global epistaxis device market trends?
  • Which device type will dominate the market share?
  • Which material is expected to have a high market value in the coming years? 
  • Which end-user is projected to contribute to the highest market growth? 
  • Who are the key players involved in the epistaxis device market? 
  • What is the patent landscape of the market? 
  • What are the current unmet needs and challenges in the market?
  • How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

The global epistaxis device market is projected to grow at a CAGR of nearly 5.4% in the forecast period of 2024-2032.

The major drivers of the industry include rising disposable incomes, growth in functional endoscopic sinus surgery (FESS), and the rising air pollution.

The technological advancement in epistaxis device materials used after FESS is expected to be a key trend guiding the growth of the industry.

North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa are the leading regions in the market.

The leading types of the product in the industry include nasal tampons and nasal catheters, among others.

The major application sectors of the product include anterior and posterior epistaxis.

The leading players in the market are DeRoyal Industries Inc., Pfizer Inc., Stryker Corp., and Teleflex Incorporated, among others.

Report Summary

Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.

Key Highlights of the Report

Please note that the figures mentioned in the description serve as estimates and may vary from the actual figures presented in the final report.

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Device Type
  • Material
  • Application
  • End User
  • Region
Breakup by Device Type
  • Nasal Packing Devices
  • Nasal Tampons
  • Nasal Sponges
  • Nasal Plugs
  • Cryotherapy Devices
  • Others
Breakup by Material
  • Silicone
  • Polyurethane
  • Polyethylene
  • Natural Materials
  • Others
Breakup by Application
  • Anterior Epistaxis Treatment
  • Posterior Epistaxis Treatment
  • Chronic Epistaxis Treatment
  • Traumatic Epistaxis Treatment
  • Others
Breakup by End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty clinics
  • Homecare
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • PESTEL Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Company News and Developments
    • Certifications
Companies Covered
  • Medtronic plc
  • Smith & Nephew plc
  • Johnson & Johnson (Ethicon)
  • Stryker Corporation
  • Cook Group
  • Olympus Corporation
  • Boston Scientific Corporation
  • Karl Storz SE & Co. KG
  • AbbVie Inc.

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,499

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,699

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,599

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,599

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63-287-899-028, +63-967-048-3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63-287-899-028, +63-967-048-3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124